791334612	791334612	CD	B-NP	O
|	|	NNP	I-NP	O
RKHHS	RKHHS	NNP	I-NP	O
|	|	VBD	B-VP	O
86184483	86184483	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8780526	8780526	CD	B-NP	O
|	|	CC	I-NP	O
10/14/2003	10/14/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
asthma/copd	asthma/copd	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/6/2003	3/6/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/6/2003	5/6/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CAPPELLINI	CAPPELLINI	NNP	B-NP	O
,	,	,	O	O
MASON	MASON	NNP	B-NP	O
535-69-15-7	535-69-15-7	CD	I-NP	O
Kaneatl	Kaneatl	NNP	I-NP	O
Dence	Dence	NNP	I-NP	O
Walis	Walis	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ONC	ONC	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/17/03	5/17/03	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MACDIARMID	MACDIARMID	NNP	B-NP	O
,	,	,	O	O
SAMUEL	SAMUEL	NNP	B-NP	O
TEODORO	TEODORO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	O	O
wheeze	wheeze	VB	B-VP	O
COLACE	COLACE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
EPOGEN	EPOGEN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EPOETIN	EPOETIN	NNP	I-NP	O
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/24	11/24	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ROBITUSSIN	ROBITUSSIN	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
cough	cough	NN	I-NP	O
MAALOX	MAALOX	NN	I-NP	O
PLUS	PLUS	NN	I-NP	O
EX	EX	NN	I-NP	O
.	.	.	O	O

STR	STR	NN	B-NP	B-protein
.	.	.	O	O

15	15	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
PO	PO	NN	I-NP	B-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Indigestion	Indigestion	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
8/15/03	8/15/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
11/9/03	11/9/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
9/20/03	9/20/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
10/30/03	10/30/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
11/7/03	11/7/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
3/27/03	3/27/03	CD	B-NP	O
-03	-03	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Starting	Start	VBG	B-VP	O
Today	Today	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/3	5/3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SENNA	SENNA	NN	I-NP	B-protein
TABLETS	TABLETS	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
VERAPAMIL	VERAPAMIL	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEAS	RELEAS	NN	B-NP	B-protein
240	240	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
or	or	CC	O	O
hr	hr	NN	B-NP	O
<	<	JJR	B-NP	O
55	55	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ATROVENT	ATROVENT	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
QID	QID	NNP	I-NP	O
SEREVENT	SEREVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/20/03	3/20/03	CD	B-NP	O
by	by	IN	B-PP	O
VIENS	VIENS	NN	B-NP	B-protein
,	,	,	O	O
GENARO	GENARO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
TESSALON	TESSALON	NNP	B-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
cough	cough	NN	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
500	500	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	B-protein
X	X	SYM	B-NP	I-protein
7	7	CD	I-NP	I-protein
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/9	1/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
finish	finish	VB	B-VP	O
7	7	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
total	total	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
days	day	NNS	I-NP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	B-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/20/03	3/20/03	CD	B-NP	O
by	by	IN	B-PP	O
RADEKE	RADEKE	NN	B-NP	O
,	,	,	O	O
CHRIS	CHRIS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SEREVENT	SEREVENT	NN	B-NP	O
INH	INH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
37380341	37380341	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
WELLBUTRIN	WELLBUTRIN	NN	B-NP	O
SR	SR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BUPROPION	BUPROPION	NN	I-NP	O
HCL	HCL	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
PULMICORT	PULMICORT	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BUDESONIDE	BUDESONIDE	NNP	I-NP	O
ORAL	ORAL	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
SPACER	SPACER	NN	I-NP	O
1	1	CD	I-NP	O
EA	EA	NN	I-NP	O
INH	INH	NN	I-NP	O
to	to	TO	B-PP	O
bedside	bedside	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
FOR	FOR	IN	B-PP	O
PATIENT	PATIENT	NNP	B-NP	O
'S	'S	POS	B-NP	O
AVAPRO	AVAPRO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IRBESARTAN	IRBESARTAN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
150	150	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOME	HOME	NNP	I-NP	O
GLUCOSE	GLUCOSE	NNP	I-NP	B-protein
MONITOR	MONITOR	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
EA	EA	NNP	I-NP	O
x1	x1	CD	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/3	5/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
also	also	RB	B-ADVP	O
provided	provide	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
script	script	NN	I-NP	O
for	for	IN	B-PP	O
lancets	lancet	NNS	B-NP	O
&	&	CC	I-NP	O
test	test	NN	I-NP	O
strips	strip	NNS	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
supply	supply	NN	I-NP	O
&	&	CC	O	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
MD	MD	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NN	B-NP	I-protein
>	>	SYM	O	O
400	400	CD	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
finger	finger	NN	B-NP	O
stick	stick	NN	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lemuel	Lemuel	NNP	I-NP	O
Lingelbach	Lingelbach	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
5487122911	5487122911	CD	B-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
doctor	doctor	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
RH	RH	NN	B-NP	O
asthma	asthma	NN	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
Antama	Antama	NNP	B-NP	O
Ln	Ln	NNP	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Fujisawa	Fujisawa	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
Monday	Monday	NNP	I-NP	O
April	April	NNP	I-NP	O
scheduled	schedule	VBD	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Erythromycins	Erythromycins	NNP	B-NP	O
,	,	,	O	O
Shellfish	Shellfish	NNP	B-NP	O
,	,	,	O	O
Nsaid	Nsaid	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
asthma/copd	asthma/copd	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
r/o	r/o	DT	B-NP	O
MI	MI	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
DM	DM	NNP	I-NP	O
Asthma	Asthma	NNP	I-NP	O
Obesity	Obesity	NNP	I-NP	O
Sleep	Sleep	NNP	I-NP	O
apnea	apnea	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pre-syncope	pre-syncope	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
near	near	IN	B-PP	O
syncope	syncope	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
NHL	NHL	NN	I-NP	O
s/p	s/p	NN	I-NP	O
chop	chop	NN	I-NP	O
11/19	11/19	CD	I-NP	O
h/o	h/o	NN	I-NP	O
PNA	PNA	NN	I-NP	O
5/29	5/29	CD	I-NP	O
ppd	ppd	NN	I-NP	O
positive	positive	JJ	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
NHL	NHL	NN	B-NP	O
,	,	,	O	O
asthma/copd	asthma/copd	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
LLL	LLL	NNP	I-NP	O
PNA	PNA	NNP	I-NP	O
5/29	5/29	CD	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
obesity/osa	obesity/osa	NN	B-NP	O
,	,	,	O	O
p/w	p/w	NN	B-NP	O
sob	sob	NN	I-NP	O
&	&	CC	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
viral	viral	JJ	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
mild	mild	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	I-VP	O
comfortable	comfortable	JJ	B-ADJP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
RA	RA	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
peak	peak	NN	I-NP	O
flows	flow	VBZ	B-VP	O
300	300	CD	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
approx	approx	NN	I-NP	O
5L	5L	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
home	home	NN	B-NP	O
asthma	asthma	NN	I-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
finish	finish	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
course	course	NN	I-NP	O
&	&	CC	I-NP	O
short	short	JJ	I-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
clinic	clinic	NN	I-NP	O
referall	referall	NN	I-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
s/p	s/p	NN	B-NP	O
CHOP	CHOP	NN	I-NP	O
for	for	IN	B-PP	O
NHL	NHL	NN	B-NP	B-protein
3/12/03	3/12/03	CD	I-NP	I-protein
.	.	.	O	O

recent	recent	JJ	B-NP	O
admit	admit	NN	I-NP	O
to	to	TO	B-PP	O
CCHO	CCHO	NN	B-NP	B-DNA
5/29	5/29	CD	I-NP	I-DNA
for	for	IN	B-PP	O
fever/neutropenia	fever/neutropenia	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
chemotx	chemotx	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
LLL	LLL	NN	I-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
cx	cx	NN	B-NP	O
's	's	POS	B-NP	O
grew	grew	JJ	I-NP	O
nl	nl	NN	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
rx	rx	NN	B-NP	O
'd	'd	MD	B-VP	O
w	w	VB	I-VP	O
/	/	SYM	B-NP	O
biaxin	biaxin	NN	I-NP	O
x	x	SYM	B-NP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
mild	mild	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
short	short	JJ	B-NP	O
pred	pred	JJ	I-NP	O
taper	taper	NN	I-NP	O
;	;	:	O	O
also	also	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBN	B-VP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
iv	iv	NN	I-NP	O
lasix	lasix	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
d/c	d/c	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
intermitant	intermitant	JJ	I-NP	O
SOB	SOB	NN	I-NP	O
2/2	2/2	CD	I-NP	O
asthma	asthma	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
cold	cold	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

4-6	4-6	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
dtr	dtr	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
viral	viral	JJ	I-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
increased	increase	VBN	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
incr	incr	NN	B-NP	O
wob/doe	wob/doe	NN	I-NP	O
,	,	,	O	O
rx	rx	NN	B-NP	O
'd	'd	MD	B-VP	O
w	w	VB	I-VP	O
/	/	SYM	B-NP	O
home	home	NN	I-NP	O
neb	neb	NN	I-NP	O
4-6x	4-6x	NN	I-NP	O
qd	qd	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
symptoms	symptom	NNS	B-NP	O
worse	worse	JJR	B-ADJP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

peak	peak	NN	B-NP	O
flows	flow	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
PFs	PF	NNS	I-NP	I-protein
-RRB-	-RRB-	``	B-NP	O
nl	nl	NN	I-NP	O
'	'	''	I-NP	O
y	y	NN	I-NP	O
350-400	350-400	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
doa	doa	NN	B-NP	O
,	,	,	O	O
PF	PF	NN	B-NP	O
250-270	250-270	CD	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
11/27	11/27	CD	B-NP	O
5	5	CD	I-NP	O
lb	lb	NN	I-NP	O
wt	wt	NN	I-NP	O
gain	gain	NN	I-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
wk	wk	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
incr	incr	NN	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
incr	incr	NN	B-NP	O
home	home	NN	I-NP	O
lasix	lasix	NN	I-NP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

ED	ED	VBN	B-NP	O
VS	VS	NN	I-NP	B-protein
T97	T97	NN	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
92	92	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
118/78	118/78	CD	I-NP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
,	,	,	O	O
given	give	VBN	B-PP	O
atrovent/alb	atrovent/alb	NN	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
IV	IV	CD	I-NP	O
lasix	lasix	NN	I-NP	O
;	;	:	O	O
BNP	BNP	NN	B-NP	B-protein
96	96	CD	I-NP	I-protein
;	;	:	O	O
WBC	WBC	NNP	B-NP	O
6.7	6.7	CD	I-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
wnl	wnl	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
no	no	DT	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
infiltrates	infiltrate	NNS	B-NP	O
,	,	,	O	O
effusions	effusion	NNS	B-NP	O
;	;	:	O	O
LUNG	LUNG	NN	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
ant-diffuse	ant-diffuse	JJ	B-NP	O
bilat	bilat	NN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
&	&	CC	B-NP	O
course	course	NN	I-NP	O
upper	upper	JJ	I-NP	O
airway	airway	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
LLL	LLL	NN	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
decr	decr	NN	B-NP	O
.	.	.	O	O

air	air	NN	B-NP	O
movement	movement	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM/ID	PULM/ID	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	PDT	B-NP	O
a	a	DT	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5/8	5/8	CD	I-NP	O
no	no	DT	B-NP	O
o2	o2	NN	I-NP	B-protein
requirement	requirement	NN	B-VP	I-protein
96	96	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
2L	2L	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
b	b	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
nebs	neb	NNS	I-NP	I-protein
,	,	,	O	O
nebs	neb	NNS	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
inhalers	inhaler	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
c	c	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
5/8	5/8	CD	I-NP	O
iv	iv	NN	I-NP	O
solumedrol	solumedrol	NN	I-NP	O
80	80	CD	B-NP	O
tid	tid	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
taper	taper	NN	B-NP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
prednisone	prednisone	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
peak	peak	JJ	I-NP	O
flows	flow	NNS	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
300	300	CD	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
max	max	NN	I-NP	B-protein
home	home	NN	I-NP	I-protein
peak	peak	NN	I-NP	I-protein
flow	flow	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
400	400	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
short	short	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
12	12	CD	B-NP	O
day	day	NN	I-NP	O
Levoquin	Levoquin	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
resume	resume	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
asthma	asthma	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
referal	referal	JJ	B-ADJP	O
to	to	TO	B-PP	O
JLMC	JLMC	NN	B-NP	O
asthma	asthma	NN	I-NP	O
clinic	clinic	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
5/8	5/8	CD	I-NP	I-cell_line
6.7	6.7	CD	I-NP	I-cell_line
,	,	,	O	O
2/23	2/23	CD	B-NP	O
s/p	s/p	NN	I-NP	O
IV	IV	CD	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
wbc	wbc	NN	B-NP	O
13.7	13.7	CD	I-NP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
peak	peak	NN	B-NP	O
14s	14	NNS	I-NP	O
,	,	,	O	O
afebrile	afebrile	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
sputum	sputum	NN	I-NP	O
culture	culture	NN	I-NP	O
that	that	WDT	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
only	only	RB	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
12	12	CD	B-NP	O
day	day	NN	I-NP	O
levoquin	levoquin	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
March	March	NNP	B-NP	O
vol	vol	NN	I-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
EF	EF	NN	I-NP	O
11/25	11/25	CD	B-NP	O
60-65	60-65	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
5/8	5/8	CD	I-NP	O
lasix	lasix	CD	I-NP	O
40iv	40iv	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
goal	goal	NN	B-NP	B-protein
1-1	1-1	CD	I-NP	I-protein
.5	.5	CD	I-NP	I-protein
L	L	NN	I-NP	I-protein
neg	neg	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
b	b	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
rest	rest	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
daily	daily	JJ	B-NP	O
wts	wt	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
diuresed	diurese	VBD	B-VP	O
a	a	DT	B-NP	O
net	net	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
5-6	5-6	CD	I-NP	O
Ls	L	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpt	outpt	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-NP	O
lasix	lasix	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

reduction	reduction	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mild	mild	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-PP	O
follow-up	follow-up	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
outpt	outpt	JJ	I-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
c	c	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
sbp	sbp	NN	I-NP	O
5/8	5/8	CD	B-NP	O
130	130	CD	I-NP	O
-	-	HYPH	B-NP	O
140s	140s	CD	I-NP	O
,	,	,	O	O
cont	cont	JJ	B-NP	O
avapro	avapro	NN	I-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
sbps	sbp	VBZ	B-VP	O
130s	130s	CD	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
GI-bowel	GI-bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Can	Can	MD	B-VP	O
decide	decide	VB	I-VP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
if	if	IN	B-SBAR	O
need	need	NN	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
nexium	nexium	NN	B-NP	O
past	past	JJ	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
prescription	prescription	NN	I-NP	O
&	&	CC	O	O
when	when	WRB	B-ADVP	O
pt	pt	JJ	B-NP	O
done	do	VBN	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
5/8	5/8	CD	B-NP	O
cr	cr	NN	I-NP	O
1.1	1.1	CD	B-NP	O
2/23	2/23	CD	I-NP	O
s/p	s/p	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
cr	cr	NN	B-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
electrolyes	electrolye	NNS	B-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
without	without	IN	B-PP	O
issues	issue	NNS	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
ada	ada	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
cont	cont	JJ	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
czi	czi	NNS	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
high	high	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
>	>	SYM	O	O
400	400	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
following	follow	VBG	B-PP	O
start	start	NN	B-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
rest	rest	NN	B-NP	O
averaging	average	VBG	B-VP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
glycemic	glycemic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
&	&	CC	I-NP	O
a	a	DT	I-NP	O
rapid	rapid	JJ	I-NP	O
,	,	,	I-NP	O
short	short	JJ	I-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
for	for	IN	B-PP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
after	after	IN	B-PP	O
taper	taper	NN	B-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
pending	pende	VBG	B-PP	O
h	h	NN	B-NP	O
emoglobin	emoglobin	NN	I-NP	O
a1c	a1c	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
states	state	VBZ	B-VP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
home	home	NN	B-NP	O
glucose	glucose	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
prescriptions	prescription	NNS	B-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
glucose	glucose	NN	I-NP	O
monitorin	monitorin	NN	I-NP	O
and	and	CC	I-NP	O
instructions	instruction	NNS	I-NP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
BID	BID	NN	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
MD	MD	NNP	B-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
>	>	SYM	B-VP	O
400	400	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Psych	Psych	NNP	I-NP	O
:	:	:	O	O
cont	cont	VB	B-VP	O
wellbutrin	wellbutrin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme/Onc	Heme/Onc	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	PDT	B-NP	O
a	a	DT	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HCT	HCT	NN	I-NP	O
5/8	5/8	CD	I-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
2/23	2/23	CD	B-NP	O
33.5	33.5	CD	I-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
futher	futh	JJR	I-NP	O
issues	issue	NNS	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
b	b	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
c	c	NN	I-NP	I-protein
-RRB-	-RRB-	CC	O	I-protein
full	full	JJ	B-NP	I-protein
code	code	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
d	d	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
off	off	IN	B-PP	O
chemotx	chemotx	NN	B-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
scan	scan	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
s/p	s/p	VBP	B-VP	O
her	her	PRP$	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
followup	followup	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
her	her	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
wheezinge	wheezinge	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
reoccur	reoccur	NN	B-NP	O
,	,	,	O	O
worsen	worsen	VBN	B-VP	O
,	,	,	O	O
or	or	CC	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
way	way	NN	I-NP	O
concerning	concern	VBG	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
&	&	CC	O	O
your	your	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Watch	Watch	NNP	I-NP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
&	&	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
gaining	gain	VBG	I-VP	O
to	to	TO	B-PP	O
much	much	JJ	B-NP	O
weight	weight	NN	I-NP	O
or	or	CC	I-NP	O
feeling	feeling	NN	I-NP	O
dizzy	dizzy	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
lightheaded	lightheade	VBN	I-ADJP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	SYM	O	O
Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
time/day	time/day	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Check	Check	NNP	I-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
2	2	CD	I-NP	O
times/day	times/day	NN	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
MD	MD	NNP	B-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
>	>	SYM	B-NP	O
400	400	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Follow-up	Follow-up	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
f/u	f/u	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
peak	peak	NN	I-NP	O
flows	flow	NNS	I-NP	O
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
and	and	CC	O	O
titrate	titrate	NN	B-NP	O
asthma	asthma	NN	I-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
requests	request	VBZ	B-VP	O
referral	referral	NN	B-NP	O
to	to	TO	B-PP	O
MH	MH	NN	B-NP	O
asthma	asthma	NN	I-NP	O
clinic	clinic	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
F/u	F/u	NNP	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
&	&	CC	O	O
electrolytes	electrolyte	NNS	B-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
and	and	CC	O	O
titrate	titrate	NN	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
F/u	F/u	NN	I-NP	B-protein
blood	blood	NN	I-NP	I-protein
sugars	sugar	NNS	I-NP	I-protein
after	after	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
ends	end	VBZ	B-VP	O
&	&	CC	B-NP	O
f/u	f/u	NN	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
a1c	a1c	NN	I-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
f/u	f/u	NN	I-NP	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	O
still	still	RB	B-ADVP	O
requires	require	VBZ	B-VP	O
nexium	nexium	JJ	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
prednisone	prednisone	NN	I-NP	I-protein
taper	taper	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
only	only	RB	B-VP	I-protein
given	give	VBN	I-VP	I-protein
1	1	CD	B-NP	I-protein
month	month	NN	I-NP	I-protein
supply	supply	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BOEKEN	BOEKEN	NNP	B-NP	O
,	,	,	O	O
HAL	HAL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SE68	SE68	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/17/03	5/17/03	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
48	48	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

